 Connection
Donald Bodenner to Iodine Radioisotopes
This is a "connection" page, showing publications Donald Bodenner has written about Iodine Radioisotopes.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.590 |
|
|
|
-
Frank RW, Middleton L, Stack BC, Spencer HJ, Riggs AT, Bodenner DL. Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinoma. Head Neck. 2014 Feb; 36(2):155-7.
Score: 0.440
-
Cabanillas ME, Schlumberger M, Jarzab B, Martins RG, Pacini F, Robinson B, McCaffrey JC, Shah MH, Bodenner DL, Topliss D, Andresen C, O'Brien JP, Ren M, Funahashi Y, Allison R, Elisei R, Newbold K, Licitra LF, Sherman SI, Ball DW. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment. Cancer. 2015 Aug 15; 121(16):2749-56.
Score: 0.125
-
Francis CL, Nalley C, Fan C, Bodenner D, Stack BC. 18F-fluorodeoxyglucose and 131I radioguided surgical management of thyroid cancer. Otolaryngol Head Neck Surg. 2012 Jan; 146(1):26-32.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|